IQVIA Inc. (IQV)
185.85
1.59 (0.86%)
At close: Mar 21, 2025, 3:59 PM
193.58
4.16%
After-hours: Mar 21, 2025, 06:16 PM EDT
0.86% (1D)
| Bid | 180.03 |
| Market Cap | 32.77B |
| Revenue (ttm) | 14.98B |
| Net Income (ttm) | 1.34B |
| EPS (ttm) | 7.5 |
| PE Ratio (ttm) | 24.78 |
| Forward PE | 17.09 |
| Analyst | Buy |
| Ask | 207.06 |
| Volume | 1,112,704 |
| Avg. Volume (20D) | 1,363,505 |
| Open | 182.85 |
| Previous Close | 184.26 |
| Day's Range | 180.00 - 185.94 |
| 52-Week Range | 179.28 - 254.80 |
| Beta | 1.51 |
About IQV
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation serv...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date May 9, 2013
Employees 88,000
Stock Exchange NYSE
Ticker Symbol IQV
Website https://www.iqvia.com
Analyst Forecast
According to 18 analyst ratings, the average rating for IQV stock is "Buy." The 12-month stock price forecast is $250, which is an increase of 34.52% from the latest price.
Stock ForecastsNext Earnings Release
IQVIA Inc. is scheduled to release its earnings on May 1, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+2.2%
IQVIA Holdings shares are trading higher after the...
Unlock content with
Pro Subscription
3 months ago
+3%
IQVIA Holding shares are trading higher after Stephens & Co initiated coverage on the stock with an Overweight rating on the stock and announced a $250 price target.
